A list of commonly used measurement tools for psoriasis management and clinical trials.
General
A simple 10-question validated questionnaire that has been used in over 40 different skin conditions in over 80 countries and is available in over 90 languages to measure disease severity and quality of life.
Link and free download available
To express the severity of psoriasis by measuring redness, thickness, and scaliness of the lesions, weighed by the area of involvement.
PGA: Physician's Global Assessment
Physician's assessment of the severity of disease based on a scale from clear to very severe.
A 10-question questionnaire based on the experiences of children with skin disease. Available in both a text-only version as well as The Cartoon CDLQI, with each question illustrated by a cartoon based on the theme of the question, catering to younger children.
PEST is a validated screening tool for psoriatic arthritis (PsA) and it is recommended that patients with psoriasis who do not have a diagnosis of PsA complete an annual PEST questionnaire (NICE psoriasis guidelines 2012). A score of 3 or more indicates referral to rheumatology should be considered.
A clinical outcome measure for the assessment of genital psoriasis severity that accounts for the erythematous clinical presentation of genital psoriasis
HELP US ENHANCE OUR LIST OF AVAILABLE MEASUREMENT TOOLS. SEND INFORMATION AND LINKS TO INFO@PSORIASISCOUNCIL.ORG
congress coverage EADV 2019 Read the psoriasis highlights from the EADV 2019 congress learn more
Psoriasis News Statement on the Coronavirus (COVID-19) Outbreak3/11/2020 1:09:00 PMFor psoriasis patients diagnosed with COVID-19 disease, the IPC recommends physicians discontinue or postpone use of immunosuppressant medications. This is in accordance with established psoriasis treatment guidelines, which state immunosuppressive psoriasis treatments are contraindicated in patients with active infections. NOW AVAILABLE: IPC's January 2020 Psoriasis Review newsletter2/6/2020 10:54:00 AMJust published - IPC's latest issue of the Psoriasis Review newsletter is now available! This issue features the Top Five Papers in psoriasis research, symposia reports, IPC news, and more! IPC Think Tank 20192/6/2020 AbbVie Launches Let Me Be Clear to Empower People with Psoriasis to Speak Up and Seek Freedom from Their Disease11/5/2019 9:16:00 AMAbbVie, a research-based global biopharmaceutical company, today announced the launch of Let Me Be Clear, an empowerment platform for people living with psoriasis. The initiative, which launches on World Psoriasis Day, invites people living with psoriasis to share their story, discuss what freedom from psoriasis would mean to them and access tools to have clear and informed conversations with their physicians. More News